Solid Biosciences Inc. · NASDAQ:SLDB

Vestal Point Capital, LP reported a 7.50% stake in Solid Biosciences Inc. (Schedule 13G)

Event Dec 31, 2025 · Filed Feb 17, 2026

Vestal Point Capital, LP reported a 7.50% stake in Solid Biosciences Inc., 5,815,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).

Stake
7.50%
Shares
5,815,000
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Vestal Point Capital, LP7.50%5,815,000
Ryan Wilder7.50%5,815,000

Source

View original at SEC

Related